What is eClipse Enterprise Solutions?
eClipse Enterprise Solutions operates as a specialized clinical technology partner, providing a comprehensive ecosystem of regulatory and data management services. Their core offerings include Electronic Data Capture (EDC), Interactive Response Technology (IRT), and Identification of Medicinal Products (IDMP) compliance, alongside Clinical Trial Management Systems (CTMS) and medical coding. By maintaining an ISO9001:2015 registration and fostering a strategic partnership with Oracle, the firm distinguishes itself through a high-touch, collaborative approach to trial management. The company serves as a critical infrastructure provider for pharmaceutical and biotech organizations, ensuring that complex clinical data is managed with precision, regulatory adherence, and operational efficiency.
How much funding has eClipse Enterprise Solutions raised?
eClipse Enterprise Solutions has raised a total of $95K across 1 funding round:
Debt
$95K
Debt (2021): $95K with participation from PPP
Key Investors in eClipse Enterprise Solutions
PPP
Public-Private Partnership
What's next for eClipse Enterprise Solutions?
With the infusion of this latest investment, eClipse Enterprise Solutions is expected to scale its operational capacity and deepen its technological integration capabilities. The firm will likely focus on expanding its footprint in the clinical trial software market, potentially enhancing its automated coding and data management platforms to meet the evolving demands of global regulatory bodies. As the company transitions through this significant Series B/C stage, the focus will remain on maintaining its reputation for client-centric service while scaling its infrastructure to support larger, more complex multi-center trials. Future growth will likely be driven by the continued adoption of its Oracle-integrated solutions and the expansion of its regulatory compliance service offerings.
See full eClipse Enterprise Solutions company page
